Intratumoral delivery of tumor antigen-loaded DC and tumor-primed CD4+ T cells combined with agonist α-GITR mAb promotes durable CD8+ T-cell-dependent antitumor immunity
The progressive tumor microenvironment (TME) coordinately supports tumor cell expansion and metastasis, while it antagonizes the survival and (poly-)functionality of antitumor T effector cells. There remains a clear need to develop novel therapeutic strategies that can transform the TME into a pro-i...
Main Authors: | Zuqiang Liu, Xingxing Hao, Yi Zhang, Jiying Zhang, Cara D. Carey, Louis D. Falo, Walter J. Storkus, Zhaoyang You |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-06-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1315487 |
Similar Items
-
Treatment of advanced tumors with agonistic anti-GITR mAb and its effects on tumor-infiltrating Foxp3[+]CD25[+]CD4[+] regulatory T cells
by: Ko, Kuibeom
Published: (2011) -
CD8+ T Cells: GITR Matters
by: Simona Ronchetti, et al.
Published: (2012-01-01) -
GITR ligand fusion protein agonist enhances the tumor antigen–specific CD8 T-cell response and leads to long-lasting memory
by: Nick M. Durham, et al.
Published: (2017-06-01) -
The Role of TNFR Family Members GITR and CD30 on CD8 T Cell Responses
by: Snell, Laura Margaret Lucette
Published: (2012) -
The Role of TNFR Family Members GITR and CD30 on CD8 T Cell Responses
by: Snell, Laura Margaret Lucette
Published: (2012)